Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » When Kids’ Autistic Brains Can’t Calm Down
Disease Discoveries

When Kids’ Autistic Brains Can’t Calm Down

By Marla PaulApr 5, 2018
Share
Facebook Twitter Email

Mutation is linked for first time to seizures in autism and is new drug target

penzes
Peter Penzes, PhD, the Ruth and Evelyn Dunbar Professor of Psychiatry and Behavioral Sciences, was the lead author of the study that explored autism’s link to epilepsy.

One-third of children who have autism spectrum disorder also have epilepsy. It’s related to a major autism risk gene, which is mutated in patients with autism. But scientists didn’t now why the mutation, catnap2, caused seizures.

In a study published in Molecular Psychiatry, Northwestern Medicine scientists have discovered the mutation acts like a bad gardener in the brain. It shrinks the neurons’ tiny branches and leaves — its dendrite arbors and synapses — that enable brain cells to relay vital messages and control the brain’s activity. The shrinkage causes a breakdown in message delivery.

An important message that gets lost? Calm down!

In people with the mutation, inhibitory neurons — whose job is to keep things tranquil in the brain and slam the brake on excitatory neurons — don’t grow enough branches and leaves to communicate their Zen-like message, the scientists found. That leads to seizures.

The mutation, CNTNAP2 or “catnap2,” works as a team with another mutated gene, CASK, implicated in mental retardation. As a result, scientists have a new target for drugs to treat the disorder.

https://soundcloud.com/user-549060398/understanding-the-biology-of-autism-with-feinberg-scientist-peter-penzes-phd

“Now we can start testing drugs to treat the seizures as well as other problems in autism,” said lead author Peter Penzes, PhD, the Ruth and Evelyn Dunbar Professor of Psychiatry and Behavioral Sciences. “Patients with the mutation also have language delay and intellectual disability. So a drug targeting the mutation could have multiple benefits.”

Next Penzes’s team will do high-throughput screening of molecules with the goal of reversing these abnormalities in patients with autism.

Catnap2 is an adhesive molecule that helps cells stick together, in this case helping the synapses adhere to the dendrites. It’s a difficult molecule to target with drugs, Penzes said.

But catnap2’s partner, CASK, is a social butterfly enzyme that interacts with many other molecules. It can more easily be inhibited or activated with drugs. Penzes’s team will screen drugs to activate it because that appears to maintain healthy dendrite branches. When scientists blocked CASK in the study, dendrites didn’t grow.

Penzes is also director of the new Center for Autism and Neurodevelopment, which aims to speed the development of new treatments.

Autism spectrum disorder is a highly prevalent neurodevelopmental disorder — affecting one in 68 children — characterized by a range of symptoms, including difficulty with communication and social interactions. People with autism also often have other neurodevelopmental disorders and comorbidities, such as intellectual disabilities, seizure disorders or epilepsy, anxiety and depression.

The study was supported by grants NS100785, MH097216 and F30MH096457 from the National Institute of Mental Health of the National Institutes of Health.

Neurology and Neuroscience Psychiatry Research
Share. Facebook Twitter Email

Related Posts

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Comments are closed.

Latest News

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Expanded Role for Calcium Channels in T-Cells

Jun 17, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077
20220607_Feinberg Campus_0063
20220607_Feinberg Campus_0111
20220607_Feinberg Campus_0083
20220607_Feinberg Campus_0018
20220607_Feinberg Campus_0023
20220607_Feinberg Campus_0072 (2)
20220607_Feinberg Campus_0120

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.